Sex: U
Vaccine: COVID19, VARZOS
Symptoms: Epistaxis
Clinical narrative: Bloddy nose; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of epistaxis in a patient who received Herpes zoster (Zoster vaccine) (batch number YA29D) for prophylaxis.   Co-suspect products included COVID-19 vaccine (batch number GH9693) for prophylaxis.   The patient's past medical history included covid-19 (On 2nd October 2022, got covid, treated with monoclonal antibodies via infusion). Previously administered products included Covid-19 vaccine with an associated reaction of epistaxis (On 16th August 2021, received 0.3 ml booster dose  intramuscular with batch number Fc3181), Covid-19 vaccine with an associated reaction of epistaxis (On 18th February 2021, received 0.3 ml second dose intramuscular with batch number EM9809), Covid-19 vaccine with an associated reaction of epistaxis (On 29-January 2021, received 0.3ml first dose intramuscular with batch number EL9261), Covid-19 vaccine with an associated reaction of epistaxis (On 4th June 2022, received 0.3ml dose intramuscular with batch number FM7553) and Covid-19 vaccine with an associated reaction of epistaxis (On 22nd January 2022, received 0.3ml dose intramuscular with batch number FH8020). Concurrent medical conditions included chronic kidney disease (before May 1969, on 20 September 1998 treated with peritoneal dialysis), aortic stenosis (In 2011. bovine replacement current one is wearing out) and skin cancer (removal too many to list).   On 07-NOV-2022, the patient received the 1st dose of Zoster vaccine (unknown arm). On 19-SEP-2022, the patient received COVID-19 vaccine (intramuscular, unknown arm) .3 ml. On an unknown date, an unknown time after receiving Zoster vaccine, the patient experienced epistaxis (Verbatim: Bloddy nose). The outcome of the epistaxis was not reported.   It was unknown if the reporter considered the epistaxis to be related to Zoster vaccine.     It was unknown if the company considered the epistaxis to be related to Zoster vaccine.   Additional Information: RA Receipt Date: 14-FEB-2024 Reporter was a patient. Reporter reported that including his or her covid vaccine record patient had a bloody nose from each vaccine beginning from 29th January 2021 to 17th May 2023. Patient got covid in October 2022 and was treated with monoclonal antibodies via infusion. Reporter reported that all other shots were given in the arm, usually the left. Not one of patient's doctors had all the information, everything they had was provide by patient. When patient got a vaccine patient asked for the information to pass onto them. Patient received FLU-llV4P-Free high dose on 1st October 2021. Patient received FLU-AllV4 vaccine on 8th September 2020. Patient received subsequent covid vaccine as booster dose due to weakened immune system. On 19-SEP-2022, the patient received the dose of FLU-IIV4,P-Free high dose (unknown arm) 0.3 milliliter with batch number GH9693.On an unknown date, an unknown time after receiving FLU-IIV4,P-Free high dose, the patient experienced epistaxis. Patient received covid vaccine at pharmacy or drug store. The follow-up could not be possible as the as no contact details were available.